Table 1.

Baseline characteristics determined for the study population (no, %).

Item	TCZ-HCQ (n = 56)	TCZ-RMV (n = 52)	P-value
Age, yr.	53(46−68)	61(52−70)	0.015
Gender, male (%)	45(80.4%)	32(61.5%)	0.03
Oxygen saturation%	85(69−89)	82(75−88)	0.4
Respiratory rate	29(23−31.8)	30(25−33)	0.15
Max temperature, celsius	39(38−39)	38(37.5−39)	0.05
Serum creatinine	1.2(1.1−1.6)	1.4(1.2−2)	0.041
Comorbidities
Hypertension, no. (%)	37(66.1%)	29(55.8%)	0.27
Diabetes, no. (%)	26(46.4%)	25(48.1%)	0.86
Ischemic heart disease, no. (%)	16(28.6%)	7(13.5%)	0.06
Heart failure, no. (%)	3(5.4%)	1(1.9%)	0.35
Atrial fibrillation, no. (%)	5(8.9%)	1(1.9%)	0.11
Chronic kidney disease, no. (%)	2(3.6%)	3(5.8%)	0.59
Asthma, no. (%)	10(17.9%)	4(7.7%)	0.12
Chronic obstructive pulmonary disease, no. (%)	2(3.6%)	1(1.9%)	0.6
2 or more comorbidities, no. (%)	30(53.6%)	26(50%)	0.43
Respiratory support
Supplemental oxygen at entry, no. (%)	49(87.5%)	9(17.3%)	<0.001
Mechanical ventilation need, no. (%)	25(44.6%)	43(82.7%)	<0.001
ICU admission, no. (%)	44(78.6%)	50(96.2%)	0.007

Data are expressed as median IQR.